共 77 条
[1]
Razavi-Shearer D(2018)Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study Lancet Gastroenterol Hepatol 3 383-403
[2]
Gamkrelidze I(2019)New and old biomarkers for diagnosis and management of chronic hepatitis B virus infection Gastroenterology 156 355-68.e3
[3]
Nguyen MH(2020)HBcrAg and pg RNA and the therapeutic effect in HBeAg-positive patients receiving anti-viral therapy, baseline serum HBV-RNA is a powerful predictor of response J Viral Hepat 27 837-846
[4]
Chen DS(2020)Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B Hepatol Int 14 35-46
[5]
Van Damme P(2019)Performance of serum HBcrAg in chronic hepatitis B patients with 8-year nucleos(t)ide analogs therapy Clin Res Hepatol Gastroenterol 43 301-309
[6]
Abbas Z(2017)The role of quantitative hepatitis B surface antigen revisited J Hepatol 66 398-411
[7]
Abdulla M(2016)Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound J Hepatol 65 700-710
[8]
Abou Rached A(2020)HBV genome and life cycle Adv Exp Med Biol 1179 17-37
[9]
Adda D(2022)Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues J Viral Hepat 83 594-600
[10]
Aho I(2021)On-treatment HBV RNA dynamic predicts entecavir-induced HBeAg seroconversion in children with chronic hepatitis B J Infect 68 2106-2117